Total Payments
$10,550
2024 Payments
$1,593
Companies
39
Transactions
477
Medicare Patients
8,849
Medicare Billing
$738,097
Payment Breakdown by Category
Food & Beverage$8,640 (81.9%)
Consulting$1,120 (10.6%)
Education$439.95 (4.2%)
Other$350.00 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,640 | 470 | 81.9% |
| Consulting Fee | $1,120 | 1 | 10.6% |
| Education | $439.95 | 5 | 4.2% |
| Honoraria | $350.00 | 1 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,585 | 140 | $0 (2024) |
| UCB, Inc. | $1,380 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,077 | 53 | $0 (2024) |
| Janssen Biotech, Inc. | $956.12 | 49 | $0 (2024) |
| Amgen Inc. | $607.61 | 33 | $0 (2024) |
| Biofrontera Inc. | $509.69 | 5 | $0 (2024) |
| Dermavant Sciences, Inc. | $461.02 | 37 | $0 (2024) |
| LEO Pharma Inc. | $327.82 | 19 | $0 (2024) |
| PFIZER INC. | $271.69 | 14 | $0 (2024) |
| GENZYME CORPORATION | $255.76 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,593 | 87 | ABBVIE INC. ($407.84) |
| 2023 | $1,551 | 86 | AbbVie Inc. ($419.86) |
| 2022 | $1,315 | 62 | ABBVIE INC. ($646.43) |
| 2021 | $869.57 | 50 | AbbVie Inc. ($323.00) |
| 2020 | $667.26 | 32 | AbbVie Inc. ($166.36) |
| 2019 | $2,239 | 47 | UCB, Inc. ($1,254) |
| 2018 | $1,378 | 55 | Biofrontera Inc. ($474.98) |
| 2017 | $935.96 | 58 | AbbVie, Inc. ($143.22) |
All Payment Transactions
477 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Dermatology | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: DERMATOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Inflammation & Immunology | ||||||
| 08/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,026 | 4,625 | $483,929 | $164,788 |
| 2022 | 18 | 2,349 | 4,792 | $555,594 | $193,289 |
| 2021 | 16 | 2,176 | 5,004 | $555,440 | $196,176 |
| 2020 | 16 | 2,298 | 4,501 | $561,384 | $183,844 |
Total Patients
8,849
Total Services
18,922
Medicare Billing
$738,097
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 24 | 27 | $8,691 | $3,362 | 38.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 57 | 66 | $5,168 | $2,780 | 53.8% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2022 | 21 | 21 | $10,018 | $2,471 | 24.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 14 | 14 | $7,836 | $1,999 | 25.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 32 | 48 | $4,572 | $1,782 | 39.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 11 | 11 | $5,997 | $1,438 | 24.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 39 | $123.63 | $27.54 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 670 | 1,080 | $139,374 | $65,217 | 46.8% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 46 | 50 | $59,852 | $27,075 | 45.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 417 | 655 | $97,824 | $26,215 | 26.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 142 | 164 | $33,292 | $13,058 | 39.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 154 | 177 | $31,256 | $12,944 | 41.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 336 | 2,408 | $84,280 | $11,629 | 13.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 148 | 148 | $28,465 | $10,133 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 78 | $14,929 | $6,751 | 45.2% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2021 | 13 | 18 | $12,783 | $6,103 | 47.7% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 23 | 30 | $9,657 | $3,712 | 38.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 74 | 83 | $6,499 | $3,258 | 50.1% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 22 | 26 | $11,960 | $3,117 | 26.1% |
| 12051 | Repair of wound (2.5 centimeters or less) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 27 | 28 | $13,357 | $3,103 | 23.2% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 12 | 12 | $6,542 | $1,582 | 24.2% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 26 | 33 | $3,143 | $1,439 | 45.8% |
| 69100 | Biopsy of ear | Office | 2021 | 14 | 14 | $2,226 | $840.39 | 37.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 711 | 1,055 | $136,148 | $49,354 | 36.3% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2020 | 53 | 58 | $69,428 | $30,049 | 43.3% |
About Dr. Michael Bryan, MD
Dr. Michael Bryan, MD is a Dermatology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356443196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bryan, MD has received a total of $10,550 in payments from pharmaceutical and medical device companies, with $1,593 received in 2024. These payments were reported across 477 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($8,640).
As a Medicare-enrolled provider, Bryan has provided services to 8,849 Medicare beneficiaries, totaling 18,922 services with total Medicare billing of $738,097. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Las Vegas, NV
- Active Since 09/02/2006
- Last Updated 01/31/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1356443196
Products in Payments
- Cimzia (Drug) $1,361
- SKYRIZI (Biological) $1,097
- RINVOQ (Biological) $623.20
- COSENTYX (Biological) $621.91
- Ameluz (Drug) $474.98
- VTAMA (Drug) $461.02
- Humira (Biological) $453.08
- Enbrel (Biological) $431.87
- COSENTYX (Drug) $431.34
- TREMFYA (Drug) $353.97
- DUPIXENT (Biological) $282.74
- Otezla (Drug) $280.58
- EUCRISA (Drug) $250.10
- OPZELURA (Drug) $246.86
- Tremfya (Drug) $224.71
- REMICADE (Biological) $221.47
- Erivedge (Biological) $207.72
- HUMIRA (Biological) $206.12
- ENSTILAR (Drug) $156.56
- STELARA (Biological) $155.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Las Vegas
Mrs. Miriam Bettencourt, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Harry Greenberg, Md, MD
Dermatology — Payments: $970,450
Dermatology $970,450
Dr. David Cotter, Md, Phd, MD, PHD
Dermatology — Payments: $703,353
Dermatology $703,353
Dr. Robert Strimling, Md, MD
Dermatology — Payments: $76,428
Dermatology $76,428
Dr. Candace Spann, M.d, M.D
Dermatology — Payments: $26,803
Dermatology $26,803
Dr. Clifton Hall, M.d, M.D
Dermatology — Payments: $17,129
Dermatology $17,129